Biotage AB (BITGF)

Biotage AB (BITGF) Financial Statements


Biotage AB Financial Overview

Biotage AB's market cap is currently ―. The company's EPS TTM is $0.283; its P/E ratio is 56.44; and it has a dividend yield of 0.94%. Biotage AB is scheduled to report earnings on July 16, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 384.00Mkr 401.00Mkr 396.00Mkr 386.00Mkr 342.00M
Gross Profitkr 227.00Mkr 241.00Mkr 240.00Mkr 241.00Mkr 212.00M
EBITkr 68.00Mkr 97.00Mkr 93.00Mkr 96.00Mkr 62.00M
EBITDAkr 96.00Mkr 122.00Mkr 119.00Mkr 119.00Mkr 83.00M
Net Income Common Stockholderskr 74.00Mkr 65.00Mkr 57.00Mkr 71.00Mkr 46.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 441.00Mkr 388.00Mkr 312.00Mkr 349.00Mkr 311.00M
Total Assetskr 2.34Bkr 2.31Bkr 2.16Bkr 2.06Bkr 1.99B
Total Debtkr 217.00Mkr 250.00Mkr 243.00Mkr 244.00Mkr 203.00M
Net Debtkr -224.00Mkr -138.00Mkr -69.00Mkr -105.00Mkr -108.00M
Total Liabilitieskr 702.00Mkr 707.00Mkr 677.00Mkr 601.00Mkr 620.00M
Stockholders Equitykr 1.64Bkr 1.60Bkr 1.48Bkr 1.46Bkr 1.37B
Cash Flow-
Free Cash Flowkr 78.00Mkr 80.00Mkr 70.00Mkr 43.00Mkr 92.00M
Operating Cash Flowkr 99.00Mkr 97.00Mkr 88.00Mkr 57.00Mkr 104.00M
Investing Cash Flowkr -35.00Mkr -17.00Mkr -18.00Mkr -14.00Mkr -296.00M
Financing Cash Flowkr -6.00Mkr -8.00Mkr -113.00Mkr -6.00Mkr 145.00M
Currency in SEK

Biotage AB Earnings and Revenue History

Biotage AB Debt to Assets

Biotage AB Cash Flow

Biotage AB Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis